Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × avapritinib × Myeloid × Clear all

Phase

Phase 2 3 Phase 1 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Myeloid 1 Gastrointestinal 1

Conditions

Mastocytosis, Systemic 1

Interventions

nilotinib 12 Imatinib Mesylate 11 Dasatinib 3 ruxolitinib 2 posaconazole 2 fludarabine 2 bosutinib 2 asciminib 2 Cyclophosphamide 2 Busulfan 2 zanubrutinib 1 trametinib 1 pegaspargase 1 flumatinib 1 fludarabine phosphate 1 eltrombopag 1 dabrafenib 1 avapritinib 1 Thiotepa 1 Rituximab 1 Radiotherapy 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Micafungin 1 Interferons 1 Idarubicin 1 Hydroxyurea 1 Growth Hormone 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06748001 2026-02-09

Avapritinib Rollover Study

Blueprint Medicines Corporation

Phase 4 Recruiting

Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡